Medgene Receives Grant For Breast Cancer Research

Medgene has received a grant for breast cancer research and improving treatment for survivors of breast cancer. Survivors are often at risk for infection because many suffer from lymphedema, a condition in which fluid is retained because of damage to the lymphatic system. Sioux Falls is hosting the National NIH SBIR conference and this is the first NIH SBIR Phase 1 grant received in the state in three years. Sue Lancaster, Operations Director for Innovation Partners and manager of Medgene Labs and Tranzderm Solutions, discussed the grant and the research that it's being used for.